← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2012Last known activity
Jan 1, 2020
Acquired by Elevar Therapeutics on Sep 3, 2019
Timeline
2000s
- Jun 1, 2005
LSK BioPartners Inc.— Founded
2010s
- Sep 3, 2019
Elevar Therapeutics— Acquired By
Drugs by trial phase (6 distinct, 7 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT04119453Study directorPhase 2Jan 1, 2020
- NCT04119453Lead sponsorPhase 2Jan 1, 2020
- NCT04073615Lead sponsorPhase 1/Phase 2Sep 30, 2019
- NCT04073615Study directorPhase 1/Phase 2Sep 30, 2019
- NCT03707028Study directorPhase 1/Phase 2Oct 1, 2018
- NCT03707028Lead sponsorPhase 1/Phase 2Oct 1, 2018
- NCT03407976CollaboratorPhase 1/Phase 2Jun 19, 2018
- NCT03396211Lead sponsorPhase 1Dec 22, 2017
- NCT03396211Study directorPhase 1Dec 22, 2017
- NCT03042611Study directorPhase 3Feb 24, 2017
- NCT03042611Lead sponsorPhase 3Feb 24, 2017
- NCT01497704Lead sponsorPhase 1/Phase 2Apr 1, 2012
Details
- Founded
- Salt Lake City, UT, US Jun 1, 2005
- Last known activity
- Jan 1, 2020